Showing 5531-5540 of 5621 results for "".
- Group of Takeda Shareholders Call Proposed Shire Purchase “Height of Madness”https://modernod.com/news/group-of-takeda-shareholders-call-proposed-shire-purchase-height-of-madness/2480115/A group of Takeda shareholders have criticized the company’s deal to buy Shire as “the height of madness,” raising concerns over the level of debt that will need to be taken on to fund the purchase, the Financial Times reported. The group hold just over 1 percent of Takeda’
- Orasis Pharmaceuticals Closes $13 Million Series B Financinghttps://modernod.com/news/orasis-pharmaceuticals-closes-13-million-series-b-financing/2480119/Privately-held Orasis Pharmaceuticals announced the closing of a $13 million Series B financing to be used to advance Orasis’s lead product candidate, CSF-1, an eye drop being developed for the treatment of presbyopia symptoms, through completion of its phase 2b clinical trial. The proceeds will
- Tobii and Lumus Bring Eye Tracking Technology to Augmented Reality Eyewearhttps://modernod.com/news/tobii-and-lumus-bring-eye-tracking-technology-to-augmented-reality-eyewear/2480121/At the Augmented World Expo (AWE) this week, Tobii announced that it is working with Lumus, a provider of transparent displays for augmented reality (AR), to incorporate eye tracking technology as part of the Lumus DK50 AR development kit.
- Caution Needed With Artificial Intelligence in Medicine, Experts Warnhttps://modernod.com/news/caution-needed-with-artificial-intelligence-in-medicine-experts-warn/2480125/Current hype surrounding machine learning and artificial intelligence (AI) in medicine is enormous, with seemingly daily headlines declaring that some new model will change how a disease is diagnosed or treated. Experts are more cautious, though, with several speakers at the recent
- FDA Approves First Artificial Irishttps://modernod.com/news/fda-approves-first-artificial-iris/2480126/The FDA approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris is completely missing or damaged. “Patients with iris defects may experience severe vision problems, as well as dissatisfaction with the appear
- Miracles in Sight Seeks to Expand Adoption of Innovative Surgery With Prepared DMEK Graftshttps://modernod.com/news/miracles-in-sight-seeks-to-expand-adoption-of-innovative-surgery-with-prepared-dmek-grafts/2480128/Across the world, Descemet Membrane Endothelial Keratoplasty (DMEK) is becoming the standard of care for endothelial dysfunction. Miracles In Sight (MIS), a nonprofit eye bank that recovers, processes, and distributes ocular tissue, is helping reduce the learning curve for this new surgical techn
- Trump Says Drug Companies to Unveil Price Cuts in Two Weekshttps://modernod.com/news/trump-says-drug-companies-to-unveil-price-cuts-in-two-weeks/2480129/Major pharmaceutical companies will announce “voluntary, massive” cuts in drug prices in two weeks, President Donald Trump said Wednesday, without providing details, according to a
- Allergan Plans Sales of Women’s Health, Infectious Disease Unitshttps://modernod.com/news/allergan-plans-sales-of-womens-health-infectious-disease-units/2480131/Allergan plans to sell off its women’s health and infectious disease businesses as Chief Executive Brent Saunders works to end the steep slide in its share price over the last year, according to a
- Optovue Announces Retirement of Industry Veteran John Hawleyhttps://modernod.com/news/optovue-announces-retirement-of-industry-veteran-john-hawley/2480137/Optovue announced the retirement of renowned industry veteran John Hawley, the company’s senior vice president of global sales. Mr. Hawley will retire on July 1, 2018, and remain with Optovue in an advisory role. “For the past 10 years, I have worked side-by-side with John as we built Opto
- Rayner Receives CE Mark for Its Hydrophobic Fully Preloaded IOL Injection Systemhttps://modernod.com/news/rayner-receives-ce-mark-for-its-hydrophobic-fully-preloaded-iol-injection-system/2480142/Rayner has received European CE Mark for its first hydrophobic fully preloaded IOL injection system. The RayOne Hydrophobic IOL is made of a new proprietary material that is glistening-free, with a patented “Cornerstone” lens shape for stability during lens delivery and post-implantat